Literature DB >> 20693151

Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection.

Kelvin K W To1, Samson S Y Wong, Iris W S Li, Ivan F N Hung, Herman Tse, Patrick C Y Woo, Kwok-Hung Chan, Kwok-Yung Yuen.   

Abstract

PURPOSE OF STUDY: The demographics, clinical features and outcome of patients with pandemic influenza A (H1N1) 2009 infection were compared with a concurrent cohort of patients with seasonal influenza A infection. STUDY
DESIGN: The clinical and microbiological data of hospitalised adult patients admitted between 29 June and 28 October 2009, with pandemic A (H1N1) 2009 or seasonal influenza A infection, were analysed.
RESULTS: A total of 186 patients including 69 pandemic A (H1N1) and 117 seasonal influenza were analysed. The majority (75%) under 50 years of age had pandemic A (H1N1). Compared with seasonal influenza, pandemic A (H1N1) patients were younger (median age 47 years vs 76 years, p<0.001), less likely to have lower respiratory tract symptoms (46.4% vs 66.7%, p=0.007), but more likely to be obese (5.8% vs 0%, p=0.018), pregnant (7.2% vs 0.9%, p=0.027) or have no underlying predisposing factors (24.6% vs 5.1%, p<0.001). Patients with pandemic A (H1N1) were more likely to receive oseltamivir (91.3% vs 40.2%, p<0.001), but less likely to receive antibiotics (75.4% vs 90.6%, p=0.005). Respiratory failure was the reason for intensive care unit admission for all four patients with pandemic A (H1N1), but only for one of three patients with seasonal influenza. There were no statistical significant differences in the rate of intensive care unit admission or death.
CONCLUSIONS: In addition to age, several clinical parameters were different between pandemic A (H1N1) and seasonal influenza. However, since both seasonal and pandemic influenza can lead to significant morbidity and mortality, the impact of pre-existing seasonal influenza should not be underestimated during the pandemic period.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693151     DOI: 10.1136/pgmj.2009.096206

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  30 in total

1.  The Management of the 2009 pandemic Influenza A H1N1 virus infection.

Authors:  Kelvin K W To; Kwok-Yung Yuen
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

2.  Use of intravenous immunoglobulin in critically ill patients.

Authors:  Summer Donovan; Gonzalo M L Bearman
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

3.  Reply to Bernstein, Atmar, and Hoft.

Authors:  Alison Han; Jeffery K Taubenberger; Matthew J Memoli
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

4.  Comparable Disease Severity by Influenza Virus Subtype in the Acute Respiratory Infection Consortium Natural History Study.

Authors:  Christina Schofield; Rhonda E Colombo; Stephanie A Richard; Wei-Ju Chen; Mary P Fairchok; Ryan C Maves; John C Arnold; Patrick J Danaher; Robert G Deiss; Tahaniyat Lalani; Michael Rajnik; Eugene V Millar; Christian L Coles; Timothy H Burgess
Journal:  Mil Med       Date:  2020-08-14       Impact factor: 1.437

5.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

Review 6.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice.

Authors:  Kwok-Hung Chan; Anna J X Zhang; Kelvin K W To; Chris C S Chan; Vincent K M Poon; Kunyuan Guo; Fai Ng; Qi-Wei Zhang; Virtual H C Leung; Annie N Y Cheung; Candy C Y Lau; Patrick C Y Woo; Herman Tse; Wailan Wu; Honglin Chen; Bo-Jian Zheng; Kwok-Yung Yuen
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

8.  The role of initial radiologic and clinical manifestations in predicting the prognosis for pneumonia caused by H1N1 influenza virus.

Authors:  Cemil Göya; Alpaslan Yavuz; Cihad Hamidi; Mehmet Güli Cetinçakmak; Memik Teke; Salih Hattapoğlu; Abdurrahim Duşak
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

9.  High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza.

Authors:  Kelvin K W To; Anna J X Zhang; Ivan F N Hung; Ting Xu; Whitney C T Ip; Rebecca T Y Wong; Joseph C K Ng; Jasper F W Chan; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  Clin Vaccine Immunol       Date:  2012-05-09

Review 10.  Avian influenza A H5N1 virus: a continuous threat to humans.

Authors:  Kelvin Kw To; Kenneth Hl Ng; Tak-Lun Que; Jacky Mc Chan; Kay-Yan Tsang; Alan Kl Tsang; Honglin Chen; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2012-09-19       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.